5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases

TW202631129APending Publication Date: 2026-08-01ENLIVEN INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
ENLIVEN INC
Filing Date
2025-10-09
Publication Date
2026-08-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present disclosure relates to compounds and compositions for inhibition of Bcr-Abl tyrosine kinases, methods of preparing said compounds and compositions, and their use in the treatment of various cancers, such as chronic myeloid leukemia (CML).
Need to check novelty before this filing date? Find Prior Art